Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 25 09:48AM ET
231.91
Dollar change
-6.84
Percentage change
-2.87
%
IndexS&P 500 P/E30.08 EPS (ttm)7.71 Insider Own0.82% Shs Outstand181.50M Perf Week3.14%
Market Cap42.28B Forward P/E18.60 EPS next Y12.47 Insider Trans-4.40% Shs Float180.80M Perf Month9.69%
Income1.42B PEG2.83 EPS next Q2.81 Inst Own90.50% Short Float1.48% Perf Quarter-3.71%
Sales15.16B P/S2.79 EPS this Y9.72% Inst Trans0.41% Short Ratio2.18 Perf Half Y8.94%
Book/sh36.83 P/B6.30 EPS next Y11.40% ROA5.43% Short Interest2.67M Perf Year0.15%
Cash/sh9.20 P/C25.19 EPS next 5Y10.63% ROE22.84% 52W Range167.42 - 261.73 Perf YTD0.23%
Dividend Est.- P/FCF23.14 EPS past 5Y42.42% ROI7.49% 52W High-11.39% Beta1.48
Dividend TTM- Quick Ratio0.85 Sales past 5Y7.76% Gross Margin27.57% 52W Low38.52% ATR (14)6.35
Dividend Ex-Date- Current Ratio0.85 EPS Y/Y TTM32.25% Oper. Margin13.88% RSI (14)57.36 Volatility3.26% 2.44%
Employees87000 Debt/Eq2.00 Sales Y/Y TTM3.45% Profit Margin9.39% Recom1.65 Target Price273.96
Option/ShortYes / Yes LT Debt/Eq1.83 EPS Q/Q23.81% Payout0.00% Rel Volume1.90 Prev Close238.75
Sales Surprise0.65% EPS Surprise2.94% Sales Q/Q2.53% EarningsJul 22 BMO Avg Volume1.23M Price231.91
SMA205.29% SMA504.93% SMA2004.28% Trades Volume218,292 Change-2.87%
Date Action Analyst Rating Change Price Target Change
Jul-24-24Downgrade Jefferies Buy → Hold $266 → $242
Jun-06-24Initiated Goldman Buy $270
Feb-26-24Initiated Leerink Partners Outperform $290
Feb-15-24Downgrade Guggenheim Buy → Neutral
Feb-13-24Initiated BTIG Research Buy $285
Nov-02-23Downgrade Robert W. Baird Outperform → Neutral $248 → $202
Sep-06-23Initiated HSBC Securities Buy $260
Mar-17-23Initiated Truist Buy $265
Dec-06-22Initiated Cowen Outperform $251
Nov-17-22Downgrade Citigroup Buy → Neutral $275 → $245
Jul-24-24 03:26AM
Jul-23-24 09:40AM
01:49AM
01:00AM
Jul-22-24 06:30PM
04:28PM Loading…
04:28PM
01:47PM
11:25AM
10:37AM
08:15AM
07:11AM
07:00AM
Jul-17-24 11:00AM
Jul-16-24 06:28PM
Jul-12-24 06:02AM
08:30AM Loading…
Jul-11-24 08:30AM
Jul-08-24 04:15PM
Jul-01-24 08:01AM
Jun-25-24 08:00AM
Jun-18-24 08:49AM
06:13AM
Jun-13-24 12:23PM
04:32AM
Jun-12-24 08:00AM
Jun-10-24 08:00AM
Jun-06-24 03:07PM
Jun-03-24 06:28PM
May-28-24 06:04AM
May-24-24 11:17AM
May-14-24 08:00AM
04:15PM Loading…
May-09-24 04:15PM
May-07-24 06:49AM
May-04-24 09:27AM
May-03-24 12:11PM
11:49AM
11:17AM
11:00AM
10:07AM
09:43AM
09:40AM
09:31AM
08:11AM
07:09AM
03:32AM
01:05AM
12:13AM
May-02-24 11:55AM
11:47AM
10:12AM
08:10AM
08:04AM
07:11AM
07:00AM
May-01-24 04:30PM
Apr-29-24 10:26AM
09:16AM
Apr-25-24 11:34AM
10:02AM
Apr-24-24 12:34PM
Apr-23-24 09:00AM
Apr-18-24 05:00PM
Apr-17-24 12:00PM
Apr-15-24 04:15PM
Apr-08-24 04:01PM
07:41AM
Apr-04-24 09:40AM
09:08AM
Apr-02-24 11:39AM
Mar-20-24 07:44PM
Mar-15-24 01:38PM
11:30AM
Mar-13-24 12:07PM
Mar-06-24 04:15PM
Feb-27-24 08:00AM
Feb-26-24 08:00AM
Feb-23-24 09:00AM
Feb-21-24 04:15PM
Feb-16-24 12:02AM
Feb-15-24 05:34PM
10:39AM
01:30AM
Feb-14-24 06:29PM
01:00PM
09:30AM
08:10AM
07:36AM
07:33AM
07:16AM
07:00AM
Feb-09-24 09:26AM
09:15AM
Feb-06-24 09:00AM
Jan-24-24 04:15PM
Jan-18-24 12:49PM
Jan-17-24 06:00AM
Jan-10-24 06:29PM
06:16PM
Jan-03-24 10:31AM
Jan-02-24 08:15AM
Dec-29-23 09:31PM
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BOUSBIB ARISee RemarksMar 01 '24Option Exercise65.1642,8472,791,911828,430Mar 04 05:28 PM
BOUSBIB ARISee RemarksMar 01 '24Sale250.5331,6787,936,193796,752Mar 04 05:28 PM
STAUB W RICHARDSee RemarksFeb 29 '24Sale247.8014,1003,494,03415,945Mar 04 05:27 PM
Knightly Kevin CSee RemarksFeb 28 '24Option Exercise87.4013,2061,154,21113,858Mar 01 05:07 PM
Knightly Kevin CSee RemarksFeb 28 '24Sale250.178,6072,153,1765,251Mar 01 05:07 PM
Knightly Kevin CSee RemarksFeb 16 '24Option Exercise78.2112,149950,17318,061Feb 21 05:07 PM
Knightly Kevin CSee RemarksFeb 16 '24Sale241.1013,4683,247,165652Feb 21 05:07 PM
Sherbet EricSee RemarksFeb 16 '24Sale241.501,000241,50020,836Feb 21 05:08 PM
Knightly Kevin CSee RemarksDec 01 '23Option Exercise62.2618,4911,151,18520,464Dec 05 05:01 PM
Knightly Kevin CSee RemarksDec 01 '23Sale214.0313,1172,807,4727,347Dec 05 05:01 PM
Panagos ConstantinosSee RemarksSep 19 '23Option Exercise149.4526,1863,913,56340,436Sep 21 05:01 PM
Panagos ConstantinosSee RemarksSep 19 '23Sale208.6727,3175,700,34014,250Sep 21 05:01 PM